Retention data for some carbonyl derivatives of imidazo[2,1-c][1,2,4]triazine in reversed-phase systems in TLC and HPLC and their use for determination of lipophilicity. Part 1. Lipophilicity of 8-aryl-3-phenyl-6,7-dihydro-4H-imidazo[2,1-c][1,2,4]triazin-4-ones

Journal of Planar Chromatography - Modern TLC

Volumn 18, Issue 104, 2005, Pages 274-281

  Tuzimski, Tomasz ^a   Sztanke, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Correlations of log kw (HPLC) with RMW (TLC); Lipophilicity; Retention mobile phase composition relationships; RP HPLC; RP TLC

Indexed keywords

DERIVATIVES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR STRUCTURE; SILICA; SYNTHESIS (CHEMICAL); THIN LAYER CHROMATOGRAPHY;

CARBONYL DERIVATIVES; LIPOPHILICITY; OCTADECYL SILICA;

AROMATIC COMPOUNDS;

1,2,4 TRIAZINE DERIVATIVE; 8 ARYL 3 PHENYL 6,7 DIHYDRO 4H IMIDAZO[2,1 C] 1,2,4 TRIAZIN 4 ONE DERIVATIVE; ACETONITRILE; CARBONYL DERIVATIVE; DIOXANE; IMIDAZOLE DERIVATIVE; METHANOL; SILICON DIOXIDE; TETRAHYDROFURAN; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DRUG SOLUTION; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROMETRY; LIPOPHILICITY; MATHEMATICAL COMPUTING; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVERSED PHASE THIN LAYER CHROMATOGRAPHY; THIN LAYER CHROMATOGRAPHY;

EID: 24344443259     PISSN: 09334173     EISSN: None     Source Type: Journal    
DOI: 10.1556/JPC.18.2005.4.4     Document Type: Article

References (36)

1. R. Kaliszan, Quantitative Structure-Chromatographic Retention Relationships, Wiley, New York, USA, 1987, pp. 19-29.
2. R. Kaliszan, Anal. Chem. 64 (1992) 619A.
3. R. Kaliszan, Recent Advances in Quantitative Structure-Retention Relationships (QSRR). Chapter 11 in: K. Valkó (Ed.) Handbook of Analytical Separations - Volume 1, Separation Methods in Drug Synthesis and Purification (Series Editor R.M. Smith), Elsevier, Amsterdam, 2000.
4. L.R. Snyder, J.W. Dolan, and J.R. Gant, J. Chromatogr. 165 (1979) 3.
5. E. Soczewiński, Quantitative Retention-Eluent Composition Relationships in Partition and Adsorption Chromatography. Chapter 11 in: H. Issaq (Ed.) A Century of Separation Science, Marcel Dekker, New York, 2002, pp. 179-195.
6. P.J. Schoenmakers, H.A.H. Billiet, R. Tijssen, and L. De Galan, J. Chromatogr. 149 (1978) 519.
7. K. Valkó and P. Slegel, J. Chromatogr. 631 (1993) 49-61.
8. C.M. Du, K. Valkó, C. Bevan, and D. Reynolds, Anal. Chem. 69 (1997) 2022.
9. K. Valkó, C. Bevan, D. Reynolds, and M.H. Abraham, Anal. Chem. 70 (1998) 4228.
10. J.D. Krass, B. Jastorff, and H.G. Genieser, Anal. Chem. 69 (1997) 2571.
11. M.A. Quarry, R.L. Grob, and L.R. Snyder, Anal. Chem. 58 (1986) 907.
12. T. Braumann, G. Weber, and L.H. Grimme, J. Chromatogr. 261 (1983) 329.
13. M. Nakamura, T. Suzuki, K. Amano, and S. Yamada, Anal. Chim. Acta 428 (2001) 219.
14. S.F. Donovan and M.C. Pescatore, J. Chromatogr. A 952 (2002) 47.
15. T. Sławik and B. Paw, J. Liq. Chromatogr. 27 (2004) 1043-1055.
16. D. Matosiuk and K. Jóźwiak, J. Planar Chromatogr. 13 (2000) 52-56.
17. D. Matosiuk and K. Jóźwiak, J. Planar Chromatogr. 13 (2000) 130-134.
18. K. Takács-Novák, P. Perjési, and J. Vámos, J. Planar Chromatogr. 14 (2001) 42-46.
19. A. Stańczak, K. Rzeszowska-Modzelewska, and W. Lewgowd, J. Planar Chromatogr. 15 (2002) 169-176.
20. G.L. Biagi, A.M. Barbaro, and M.C. Guerra, J. Chromatogr. 41 (1969) 371-379.
21. C.B. Boyce and B.B. Milborrow, Nature 208 (1965) 537-538.
22. K. Jóźwiak, H. Szumiło, B. Senczyna, and A. Niewiadomy, SAR QSAR Environ. Res. 10 (1999) 509-532.
23. E. Soczewiński and C.A. Wachtmeister, J. Chromatogr. 7 (1962) 311-320.
24. N.P. Gesmantel. In: F.D. King (Ed.) Medicinal Chemistry: Principles and Practice, The Royal Society of Chemistry, 1994, pp. 98-113.
25. C. Hansch, J.P. Bjorkroth, and A. Leo, J. Pharm. Sci. 76 (1987) 663-687.
26. K. Sztanke and T. Tkaczyński, Acta Pol. Pharm. - Drug Res. 54 (1997) 71-74.
27. K. Sztanke and T. Tkaczyński, Acta Pol. Pharm. - Drug Res. 54 (1997) 147-149.
28. K. Sztanke and T. Tkaczyński, Acta Pol. Pharm. - Drug Res. 54 (1997) 223-224.
29. K. Sztanke, S. Fidecka, E. Kedzierska, Z. Karczmarzyk, K. Pihlaja, and D. Matosiuk, Eur. J. Med. Chem. 40 (2005) 127-134.
30. K. Sztanke, A. Sidor-Wójtowicz, J. Truchlińska, K. Pasternak, and M. Sztanke, Annales UMCS D 59 (2004) 96-99.
31. K. Sztanke, Acta Pol. Pharm. - Drug Res. 61 (2004) 373-377.
32. T. Novinson, T. Okabe, R.K. Robins, and T.R. Matthiews, J. Heterocycl. Chem. 20 (1976) 517-520.
33. T.H. Dzido and E. Soczewiński, J. Chromatogr. 561 (1990) 461-466.
34. E. Soczewiński, J. Chromatogr. A 965 (2002) 109-116.
35. L.R. Snyder, J.J. Kirkland, and J.L. Glajch. In: Practical HPLC Method Development, 2nd edn, John Wiley and Sons, New York, 1997, Appendix III, Table III.1.
36. Pallas 3.1.1.2 (distributed by CompuDrug) 2003.